 |
|
NEJM study “presents falsely reassuring statistics related
Posted on: December 13, 2021 at 00:17:41 CT
MizzouTigerz MU
Posts:
37095
Member For:
21.94 yrs
Level:
User
M.O.B. Votes:
0
Data Used to Support COVID-19 Shot in Pregnant Women Flawed
In a rapid communication from the Institute for Pure and Applied Knowledge (IPAK), Aleisha Brock, Ph.D. of New Zealand, and Simon Thornley, Ph.D., a senior lecturer in the section of epidemiology and biostatistics at the University of Auckland, explained that the NEJM study “presents falsely reassuring statistics related to the risk of spontaneous abortion in early pregnancy, since the majority of women in the calculation were exposed to the mRNA product after the outcome period was defined (20 weeks’ gestation).”11
When the risk of spontaneous abortion, or miscarriage, was recalculated based on the cohort that was injected prior to 20 weeks’ gestation, the incidence of miscarriage was seven to eight times higher than the original study indicated, with a cumulative incidence of miscarriage ranging from 82% to 91%. According to the IPAK report:12
Updated
https://www.nejm.org/doi/full/10.1056/NEJMoa2104983
Among 827 participants who had a completed pregnancy, the pregnancy resulted in a live birth in 712 (86.1%), in a spontaneous abortion in 104 (12.6%), in stillbirth in 1 (0.1%), and in other outcomes (induced abortion and ectopic pregnancy) in 10 (1.2%). A total of 96 of 104 spontaneous abortions (92.3%) occurred before 13 weeks of gestation (Table 4), and 700 of 712 pregnancies that resulted in a live birth (98.3%) were among persons who received their first eligible vaccine dose in the third trimester. Adverse outcomes among 724 live-born infants — including 12 sets of multiple gestation — were preterm birth (60 of 636 among those vaccinated before 37 weeks [9.4%]), small size for gestational age (23 of 724 [3.2%]), and major congenital anomalies (16 of 724 [2.2%]); no neonatal deaths were reported at the time of interview.
In a rapid communication from the Institute for Pure and Applied Knowledge (IPAK), Aleisha Brock, Ph.D. of New Zealand, and Simon Thornley, Ph.D., a senior lecturer in the section of epidemiology and biostatistics at the University of Auckland, explained that the NEJM study “presents falsely reassuring statistics related to the risk of spontaneous abortion in early pregnancy, since the majority of women in the calculation were exposed to the mRNA product after the outcome period was defined (20 weeks’ gestation).”11
When the risk of spontaneous abortion, or miscarriage, was recalculated based on the cohort that was injected prior to 20 weeks’ gestation, the incidence of miscarriage was seven to eight times higher than the original study indicated, with a cumulative incidence of miscarriage ranging from 82% to 91%. According to the IPAK report:12
Updated
https://www.nejm.org/doi/full/10.1056/NEJMoa2104983
Among 827 participants who had a completed pregnancy, the pregnancy resulted in a live birth in 712 (86.1%), in a spontaneous abortion in 104 (12.6%), in stillbirth in 1 (0.1%), and in other outcomes (induced abortion and ectopic pregnancy) in 10 (1.2%). A total of 96 of 104 spontaneous abortions (92.3%) occurred before 13 weeks of gestation (Table 4), and 700 of 712 pregnancies that resulted in a live birth (98.3%) were among persons who received their first eligible vaccine dose in the third trimester. Adverse outcomes among 724 live-born infants — including 12 sets of multiple gestation — were preterm birth (60 of 636 among those vaccinated before 37 weeks [9.4%]), small size for gestational age (23 of 724 [3.2%]), and major congenital anomalies (16 of 724 [2.2%]); no neonatal deaths were reported at the time of interview.
Please explain why this message is being reported.
MESSAGE THREAD
NEJM study “presents falsely reassuring statistics related - MizzouTigerz MU - 12/13 00:17:41